Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEMTX versus FEMTX-P with or without G-CSF in advanced gastric cancer
ISRCTN69546136Phase 2Completed
- Sponsor
- Pharmacia
- Start
- Jan 1996
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of methotrexate, fluorouracil, epirubicin, cisplatin, folinic acid and 1 more in gastric cancer (GC) (4 arms), sponsored by Pharmacia. Started Jan 1996; status: completed.
02
Drugs
methotrexatefluorouracilepirubicincisplatinfolinic acid
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ISRCTN69546136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69546136.